Share on LinkedInShare on LinkedIn

ARTICLE · 05 JUNE 2023

Top IP, FDA, And Compliance Issues For Medtech Companies Transitioning To Data-Enabled Product Solutions

Companies that once only developed hardware-based solutions for medical problems are now evolving into data platform companies, offering a more comprehensive glimpse into the habits and health of their patients and customers.

United StatesIntellectual Property

Companies that once only developed hardware-based solutions for medical problems are now evolving into data platform companies, offering a more comprehensive glimpse into the habits and health of their patients and customers. Many of these solutions leverage artificial intelligence (AI) and machine learning (ML), which tend to be more challenging to protect through traditional approaches.

Investor and strategic partner mindsets have shifted toward optimal ways to protect their intellectual property (IP) and meet FDA and compliance-related requirements, especially given evolving laws and social concerns.

Goodwin's Medtech practice is at the forefront of this evolution and has knowledgeable legal professionals across many fields to address the needs and concerns of companies, investors and strategic partners to medtech companies. With decades of experience working with medtech companies, our lawyers have identified key topics that companies should be aware of in

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from